From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves orally-disintegrating tablet for ADHD in children

from Psychiatry Advisor

The FDA has approved an extended-release, orally-disintegrating tablet, Adzenys XR-ODT, for the treatment of attention-deficit/hyperactivity disorder in children ages 6 and up, as well as in adults. According to the drug company, Neos Therapeutics, this is “the first and only extended-release, orally-disintegrating tablet for the treatment of ADHD.” more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063